Deepika Dilip

7PUBLICATIONS
73CO-AUTHORS
Molecular targetsMedical infection agents (incl. prions)Haematological tumoursSystems physiologyIntensive care
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Jul 31, 2026
A real-world pharmacovigilance analysis of cardiac adverse events associated with newer antibody-drug conjugates for hematological malignancies in adults: A disproportionality analysis from FDA adverse event reporting system database.

|Jan 15, 2025
Defining 2 biologically and clinically distinct groups in acute leukemia with a mixed phenotype.

Pallavi Galera, Deepika Dilip, Andriy Derkach

|Nov 14, 2023
Acute myeloid leukemia with mixed phenotype is characterized by RUNX1 mutations, stemness features and limited lineage plasticity.

Pallavi Galera, Deepika Dilip, Andriy Derkach

|Feb 24, 2023
Lenalidomide-associated B-cell ALL: clinical and pathologic correlates and sensitivity to lenalidomide withdrawal.

Mark B Geyer, Brian C Shaffer, Bhavana Bhatnagar

|Feb 22, 2023
Wearable sensor-based performance status assessment in cancer: A pilot multicenter study from the Alliance for Clinical Trials in Oncology (A19_Pilot2).

William A Wood, Deepika Dilip, Andriy Derkach

|Sep 28, 2022
The first 20 months of the COVID-19 pandemic: Mortality, intubation and ICU rates among 104,590 patients hospitalized at 21 United States health systems.

Michael C Fiore, Stevens S Smith, Robert T Adsit

Pageof 2

Frequent Collaborators

3 joint publications

Wenbin Xiao

3 joint publications

Jacob L Glass

3 joint publications

Mark B Geyer

2 joint publications

Thulasee Jose